Enroll patients. Generate evidence. Built regulatory-ready.
Two ways to bring patients into the platform. One governed infrastructure behind both. Start with commercial intelligence — real-time outcomes for your sales and medical affairs teams. Activate regulatory-grade evidence whenever you're ready, on the same patients, with no rebuild.
*Illustrative sample signals from a commercial engagement (182 patients, 16 sites) — the kind of signal the platform surfaces as a cohort matures, not a population-level claim.
Two ways in. One platform.
Choose the enrollment path that fits your commercial model — or run both. Every patient enters the same governed, HIPAA-compliant infrastructure regardless of how they arrive.
QR Code Direct-to-Celéri
Place a QR code on product packaging, patient discharge materials, trifolds, or demo kits. Patients scan and enroll directly — no rep account setup, no portal complexity, no site staff required.
- Patient scans QR code on packaging, brochure, or sales collateral
- Chooses App Path (custom-branded app or integration with an existing app) or Direct Enroll (mobile form, app optional later)
- Every patient enters the same Part 11-ready, HIPAA-compliant platform — eConsent captured digitally against governed registry infrastructure
- Automated PRO sequences begin immediately — NRS, PGIC, PROMIS-29, ODI at defined milestones
- Data flows to the sponsor Command Center in real time — no rep action required
CRM-Integrated Enrollment
For commercial organizations that want enrollment embedded directly in the rep workflow. Reps submit patients to the registry from within your existing CRM — no duplicate entry, no separate portal, no change to the pre-procedure process.
- Rep submits patient record from CRM at the pre-procedure stage
- Celéri receives the enrollment trigger — patient outreach begins automatically
- Every patient enters the same Part 11-ready, HIPAA-compliant platform — eConsent delivered via SMS or email, no site visit required
- Rep gets enrollment confirmation and milestone alerts back through the CRM
- Patient outcomes surface in the rep territory view in real time
Enroll. Engage. Signal. Act.
Four steps from patient enrollment to clinical decision — fully automated, no site staff burden.
Enroll
Patient enters via QR scan or CRM trigger. eConsent captured digitally. Tiered consent built in — commercial feedback, registry participation, or both.
Engage
Automated SMS and email sequences deliver PRO assessments at baseline and every clinical milestone. Behaviorally-informed messaging maximizes response.
Signal
Outcomes surface in real time — rep territory views, physician-level performance, indication and payer signal analysis. Benchmarked against PainRWD™ comparator data.
Act
Commercial teams use outcomes in physician conversations. Medical affairs uses the same dataset for publication and payer submissions. When ready, activate the Regulatory-Grade Evidence Cohort™ — same patients, no rebuild.
The regulatory pathway, preserved from enrollment.
The Commercial Insights Registry™ is always Layer 1 — it runs from launch and never stops. The Regulatory-Grade Evidence Cohort™ runs on top of it. Start both together, or add regulatory-grade evidence when your signals tell you it's time.
Commercial signals build first. Add the Regulatory-Grade Evidence Cohort™ later, on the same patients.
Regulatory-Grade Evidence Cohort™ runs alongside the commercial registry from launch.
Every commercial engagement preserves the regulatory pathway.
Celéri's infrastructure is designed to be 21 CFR Part 11-ready and IRB-ready from enrollment — even in pure commercial mode. That means when your signals confirm the right indication, payer segment, or geography, your evidence base is built to transition into a regulatory-grade cohort — without new infrastructure or data migration. Whether the goal is payer coverage expansion, label update, or peer-reviewed publication, the foundation is already in place.
One dataset. Two teams. No version conflict.
The most expensive data in medtech is data that has to be gathered twice. Celéri gives commercial and medical affairs access to the same governed evidence base — each with the view built for their function. One governed, HIPAA-compliant data environment; one source of truth.
Real-time outcomes intelligence
- Rep territory view: case volume, NRS trends, milestone alerts, open follow-ups
- Physician-level outcomes — blinded patient results, available in a clinical conversation
- Signal analysis by indication, payer type, and geography — no data analyst required
- MCID breach alerts routed to the assigned rep automatically
- Site FMV eligibility tracking for the Commercial Insights Program
Publication-grade evidence pathway
- Same governed cohort — draws from identical data, not a parallel extract
- Signal analysis drives cohort scoping before protocol design begins
- Longitudinal PRO dataset: NRS, PROMIS-29, ODI, PGIC, procedure timelines
- Payer dossier and HEOR modeling via PainRWD™ Science Cloud comparator data
- Celéri Research Group available for biostatistics review and manuscript support
Four views. One governed environment.
Every tab draws from the same HIPAA-compliant data infrastructure — access-controlled by role. The figures shown are illustrative sample signals — the kind of evidence Signal Analysis surfaces as a cohort matures.
Sample Command Center — Signal Analysis view. Illustrative signals, not a population-level claim.
Cohort KPIs anchored to procedure date
The primary leadership view. NRS trajectory, PGIC distribution, enrollment trends, and 30-day completion — in a single view updated in real time. 24+ KPIs available, including PROMIS-29, NRS, PGIC, EQ-5D, ODI, and custom instruments per indication.
- NRS Trajectory — mean pain by timepoint, baseline through 90 days, benchmarked to PainRWD™
- PGIC Distribution — patient-centric outcomes narrative for health-system and payer conversations
- Enrollment Trend — monthly growth by site; tracks rep engagement and site maturation
Outcomes by indication, payer, and geography
Lets clinical and market-access teams interrogate outcomes without a data analyst — and doubles as the scoping instrument for the Regulatory-Grade Evidence Cohort™, confirming the optimal indication, payer segment, and geographic cohort before protocol design.
- Indication Signal — case volume and NRS improvement by indication
- Payer Signal — outcomes by payer type for market-access discussions
- Geographic Performance — volume and NRS improvement by state
Close the loop between activity and outcomes
Commercial leadership sees, in a single governed view, which reps drive enrollment, which physicians deliver the strongest outcomes, and which patients are overdue. The physician-outcomes view is sales-enablement safe — reps filter to a physician's cohort with patient identities blinded.
- Rep Performance — cases enrolled vs. 30-day completion by rep
- Physician Outcomes — top physicians by volume and average NRS improvement
- Milestone Tracking — patients pending or overdue, for proactive outreach
Site FMV eligibility — admin view
Tracks milestone completion across enrolled patients to determine site eligibility for Fair Market Value payments in exchange for Commercial Insights Program participation. Access-controlled to authorized client and Celéri admin only — Celéri surfaces eligibility; dollar amounts and disbursement stay in your finance workflow.
- Site Eligibility Summary — sites meeting milestone thresholds this period
- Milestone Completion Funnel — attrition from consent through 90-day completion
- Access Controlled — restricted read-only; not accessible to the field team
Leading MedTech & Pharma sponsors.
Talk to a Celéri strategist.
We'll help you identify the right enrollment path and evidence tier for your product and commercial stage — whether you're at launch or seeking evidence renewal for a mature product line.
